Targeting the RNA m(6)A modification for cancer immunotherapy

N(6)-methyladenosine (m(6)A) is the most abundant epigenetic modification of RNA, and its dysregulation drives aberrant transcription and translation programs that promote cancer occurrence and progression. Although defective gene regulation resulting from m(6)A often affects oncogenic and tumor-sup...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xinxin, Ma, Shoubao, Deng, Youcai, Yi, Ping, Yu, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924732/
https://www.ncbi.nlm.nih.gov/pubmed/35296338
http://dx.doi.org/10.1186/s12943-022-01558-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924732/
https://www.ncbi.nlm.nih.gov/pubmed/35296338
http://dx.doi.org/10.1186/s12943-022-01558-0

Ejemplares similares